- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
879
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
879 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
4680 | JP¥1,310.00 | -2.3% | 134.8% | JP¥360.1b | JP¥1,352.86 | PE21.4x | E10.9% | 1.2% | Consumer Services | ||
SKC | NZ$1.45 | 0.7% | -20.3% | NZ$1.1b | NZ$1.85 | PS1.3x | E47.6% | 0% | Consumer Services | ||
CTT | AU$1.51 | 6.3% | -47.9% | AU$575.7m | AU$1.84 | PE55x | E32.0% | n/a | Retail | ||
6196 | JP¥3,655.00 | 1.5% | -24.2% | JP¥70.2b | JP¥5,900.00 | PE14.2x | E13.7% | 2.8% | Diversified Financials | ||
2292 | JP¥2,745.00 | 1.8% | -16.7% | JP¥87.3b | JP¥3,030.00 | PE27.8x | E32.9% | 3.3% | Food, Beverage & Tobacco | ||
FRAGUA B | Mex$631.28 | 5.5% | 26.3% | Mex$60.4b | Mex$1,400.00 | PE12.3x | E13.9% | 2.1% | Consumer Retailing | ||
688266 | CN¥63.53 | 2.5% | 20.0% | CN¥16.6b | CN¥79.00 | PS34.4x | E127.3% | n/a | Pharmaceuticals & Biotech | ||
002413 | CN¥4.53 | 0.4% | -16.1% | CN¥5.9b | n/a | PS5x | E105.8% | 0% | Capital Goods | ||
SUS | SEK 159.60 | 0.3% | -12.5% | SEK 8.1b | SEK 192.17 | PE42.1x | E36.1% | n/a | Healthcare | ||
4480 | JP¥3,835.00 | 0% | -12.8% | JP¥124.6b | JP¥5,675.00 | PE45.9x | E31.7% | n/a | Healthcare | ||
1928 | HK$20.65 | -3.7% | -9.6% | HK$167.1b | HK$26.09 | PE20.4x | E19.2% | 0% | Consumer Services | ||
LIAB | SEK 228.20 | 0.8% | 14.6% | SEK 17.6b | SEK 263.67 | PE25.9x | E28.5% | 2.4% | Capital Goods | ||
688526 | CN¥14.70 | 2.0% | -27.9% | CN¥6.8b | CN¥20.20 | PE22.8x | E24.3% | 2.9% | Pharmaceuticals & Biotech | ||
QNST | US$23.85 | 11.0% | 86.0% | US$1.3b | US$29.00 | PS1.7x | E105.0% | n/a | Media | ||
9250 | JP¥1,460.00 | 3.2% | -15.9% | JP¥2.0b | n/a | PS0.6x | E97.2% | n/a | Software | ||
PRGS | US$65.48 | 0.3% | 20.6% | US$2.8b | US$73.29 | PE34x | E24.5% | 0% | Software | ||
SKS | AU$1.95 | 12.8% | 548.3% | AU$218.0m | AU$2.15 | PE32.9x | E24.8% | 0.5% | Capital Goods | ||
BRCK | UK£0.64 | 2.6% | 1.6% | UK£205.3m | UK£0.97 | PE24.8x | E46.5% | 5.2% | Capital Goods | ||
HANZA | SEK 77.00 | 2.4% | -9.7% | SEK 3.4b | SEK 81.88 | PE26.5x | E34.5% | 1.6% | Tech | ||
BVC | UK£0.19 | -2.1% | -7.2% | UK£82.1m | n/a | PS0.8x | E90.4% | n/a | Tech | ||
EQL | SEK 77.80 | -2.5% | 132.9% | SEK 2.3b | SEK 65.00 | PE72.5x | E53.3% | n/a | Healthcare | ||
DE | CA$6.00 | 1.9% | -24.7% | CA$118.1m | CA$7.44 | PE46x | E55.1% | 9.0% | Capital Goods | ||
688046 | CN¥13.19 | -0.7% | -34.5% | CN¥5.5b | CN¥16.75 | PE38.6x | E27.9% | 0.5% | Pharmaceuticals & Biotech | ||
VIVA3 | R$19.27 | -3.5% | -43.7% | R$4.5b | R$32.76 | PE9.1x | E13.8% | 1.9% | Consumer Durables |